Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Protagenic Therapeutics (PTIX) has issued an announcement.
In a positive turn for investors, a company has successfully addressed its previous Nasdaq non-compliance issue by maintaining its stock price above the $1.00 minimum bid price for ten consecutive trading days. This accomplishment has resulted in the Nasdaq Listing Qualifications Department closing the deficiency notice, ensuring the company’s continued listing on the exchange and potentially restoring investor confidence in its financial stability.
For detailed information about PTIX stock, go to TipRanks’ Stock Analysis page.
